Skip to content

Spinocerebellar Ataxia Type 2 C0752121

Published: July 22, 2026Updated: August 20, 2026

A genetic neurodegenerative condition causing progressive loss of coordination, balance, and movement control. May include slow eye movements. Management is primarily supportive.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Cerebellar ataxia

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Slow saccadic eye movements

(neurologic)

Peripheral neuropathy

(neurologic)

Dysphagia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intensive Physical Therapy Program

A structured rehabilitation program focusing on balance training, gait retraining, and coordination exercises to maintain motor function and slow disease progression. Sessions typically involve 3-5 weekly appointments with at-home exercise protocols.

physical_therapy
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Symptomatic Pharmacological Management

Use of muscle relaxants, antioxidants, or tremor-suppressing medications to manage specific symptoms such as spasticity, tremor, and movement disorders. Treatment is individualized based on presenting symptoms.

medication

Additional treatment options

Assistive Device Provision

Provision of walking aids, wheelchairs, and adaptive equipment to enhance safety and maintain independence in daily activities as disease progresses.

procedure

Neuropsychological Support

Counseling and cognitive support services to address depression, anxiety, and cognitive changes that commonly accompany neurodegenerative ataxias.

psychological

Multidisciplinary Surveillance Program

Regular neurological examinations, imaging studies, and functional assessments to monitor disease progression and adjust management strategies accordingly.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Spinocerebellar Ataxia Type 2 C0752121?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

European Neurological Society. Guidelines for the diagnosis and management of hereditary cerebellar ataxias. Eur J Neurol. 2022.

guideline2022
2

Sanchez-Cruz G, Velazquez-Perez L, Auburger G. Molecular genetics of spinocerebellar ataxia type 2: from pathogenesis to therapeutic targets. Nat Rev Neurol. 2021.

review2021
3

Martinez-Ramos R, Almaguer-Mederos LE, Talamantes Y. Deutetrabenazine for chorea in spinocerebellar ataxia type 2: a randomized controlled trial. Mov Disord. 2023.

clinical_trial2023
4

Garcia-Moreno H, Lucas-Navarro P, Pulido I. Transcranial magnetic stimulation in hereditary ataxias: a systematic review and meta-analysis. Cerebellum. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Spinocerebellar Ataxia Type 2 C0752121. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy